Articles & Issues
- Language
- English
- Conflict of Interest
- In relation to this article, we declare that there is no conflict of interest.
- Publication history
-
Received June 20, 2023
Accepted September 19, 2023
- This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
All issues
Synthesis and Characterisation of Dual Z-Scheme V 2 O 5 /g-C 3 N 4 Photocatalysts for Degrading Ciprofl oxacin Antibiotics Under Visible Light
Abstract
In this research, an innovative Z-scheme vanadium pentoxide (V 2 O 5 )/graphitic carbon nitride (g-C 3 N 4 ) photocatalyst was
synthesised using a facile thermal treatment method, and its photodegradation performance and physicochemical properties
were evaluated. The heterostructure provided high Brunauer–Emmett–Teller surface area and pore volume, which encouraged
charge carrier separation and transfer, as well as supplied abundant micro-mesoporous structures and active sites for
photocatalytic redox reactions. The successful incorporation of V 2 O 5 between g-C 3 N 4 layers can be proven by proposing the
synthesis mechanism, as well as conducting morphology, crystal structure, elemental, and chemical analysis through scanning
electron microscopy, X-ray diff raction, energy dispersive X-ray spectroscopy, and X-ray photoelectron spectroscopy, respectively.
Using these combined photocatalysts, ciprofl oxacin (CIP) was successfully degraded up to 90.17% removal effi ciency
in the visible-light spectrum. The superior photocatalytic activity of g-C 3 N 4 composite over V 2 O 5 is primarily due to its
increased light absorption capacity, as well as increased surface area, pore size, and volume, eff ective charge transfer, and
optimal band alignment between g-C 3 N 4 and V 2 O 5 . This research provides a signifi cant future perspective for the utilisation
of Z-scheme V 2 O 5 /g-C 3 N 4 heterojunction photocatalyst for water treatment, especially those involving endocrine-disrupting
compounds and antibiotics like CIP.